leukemia, acute lymphocytic (all)
Showing 1 - 4 of 4
Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,
Recruiting
- Leukemia, Acute Lymphocytic (ALL)
- +2 more
- Chimeric antigen receptor T cells
- peptide specific dendritic cell
-
Guangzhou, Guangdong, ChinaZhujiang Hospital, Southern Medical University
Aug 1, 2021
Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,
Completed
- Leukemia, Acute Lymphocytic (ALL)
- +7 more
- CliniMACS
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 3, 2020
Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML) Trial run by the NCI
Completed
- Leukemia, Acute Myelogenous (AML)
- +4 more
- WT1 Peptide-Pulsed Dendritic Cells
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2017
Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,
Completed
- Leukemia, Acute Lymphocytic (ALL)
- +6 more
- Miltenyi Biotec CliniMACS
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 28, 2009